Antibiotic used in Inguinal Hernia repair
- Conditions
- Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangrene
- Registration Number
- CTRI/2021/12/038794
- Lead Sponsor
- Dr Samit Doshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) All patients undergoing elective open inguinal mesh hernioplasty.
2) Patients with Unilateral inguinal hernia and Bilateral inguinal hernia.
3) Patients giving consent for taking part in the study.
4) Patients above 18 years of age.
5) All clean hernia surgeries.
1) Patients below 18 years of age.
2) All the other hernias except inguinal hernias.
3) Patients on steroid treatment or patients with immunosuppressed states and malignancy.
4) Patients having local site infections like Tinea or Scabies.
5) All patients with complicated hernia such as Irreducible hernia, Obstructed hernia and Strangulated hernia. 6) All patients allergic to Cephalosporins.
7) All Laparoscopic hernia repairs.
8) All Recurrent inguinal hernias.
9) All clean-contaminated, contaminated and dirty hernia surgeries.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method From this study it is expected that <br/ ><br>1) multiple dose Cefotaxime does not cause a significant decrease in the rate of surgical site infection compared to single dose Cefotaxime <br/ ><br>2) Lower treatment costs for the patient and is cost effective <br/ ><br>3) Reduce the spread of antibiotic resistance <br/ ><br>4) Avoidance of side effects due to overuse of antibiotics <br/ ><br>5) Reduce hospital stayTimepoint: Assessment of patients to evaluate surgical site infection on day 3 day 5 day 7 day 15 and day 30
- Secondary Outcome Measures
Name Time Method noneTimepoint: none